Our look is new. Our purpose is the same. Learn more about our brand evolution.
FSHD researchers report in Cell that DBE-T may be a valid therapeutic target for FSHD More May 7th joint press release from San Raffaele Scientific Institute, Milan, Italy and the Telethon Foundation can be found Here